Vertex Pharmaceuticals Incorporated (BVMF:VRTX34)
618.71
+38.45 (6.63%)
At close: Dec 5, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of 625.50 billion as of December 5, 2025. Its market cap has decreased by -5.99% in one year.
Market Cap
625.50B
Enterprise Value
570.43B
Revenue
62.48B
Ranking
n/a
PE Ratio
31.94
Stock Price
618.71
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 83.36M to 625.50B, an increase of 750,269.42%. That is a compound annual growth rate of 29.62%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |